Abstract
Modulation of angiogenesis is now a recognized strategy for the prevention of various angiogenesis-mediated disorders. We investigated, using well-characterizedin vitro systems, the anti-angiogenic property of vitamin E compounds, with particular emphasis on tocotrienol, a natural analog of tocopherol. Tocotrienol, but not tocopherol, inhibited the proliferation of bovine aortic endothelial cells in dose dependent manner at half-maximal concentrations in the low micromolar range. Tocotrienol also significantly inhibited the formation of networks of elongated endothelial cells within 3D collagen gels. From these results, we suggest that tocotrienol is a potential candidate for the development of useful therapeutic agents or preventive food factors for tumor angiogenesis.
Similar content being viewed by others
REFERENCES
Serbinova, E., Kagan, V., Han, D., and Packer, L. (1991)Free Rad. Biol. Med.,10, 263–275.
Meydani, M. (1995)Lancet,345, 170–175.
Traber, M. G., and Packer, L. (1995)Am. J. Clin. Nutr.,62, 1501S–1509S.
Goh, S. H., Hew N. F., Norhanom, A. W., and Yadav, M. (1994)Int. J. Cancer,57, 529–531.
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrar, N. (1993)Nature,362, 841–844.
Shono, T., Ono, M., Izumi, H., Jimi, S. I., Matsushima, K., Okamoto, T., Kohno, K., and Kuwano, M. (1996)Mol. Cell. Biol.,16, 4231–4239.
Folkman, J., and Shing, Y. (1992)J. Biol. Chem.,267, 10931–10934.
Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y., and Ueno, K. (1996)Biol. Pharm. Bull.,19, 1518–1520.
Morales, D. E., McGowan, K. A., Grant, D. S., Maheshwari, S., Bhartiya, D., Cid, M. C., Kleinman, H. K., and Schnaper, H. W. (1995)Circulation,91, 755–763.
Kanayasu, T., Nakao-Hayashi, J., Asuwa, N., Morita, I., Ishii, T., Ito, H., and Murota, S. (1989)Biochem. Biophys. Res. Commun.,159, 572–578.
Folkman, J., and Klagsbrun, M. (1987)Science,235, 442–447.
Cao, Y., and Cao, R. (1999)Nature,398, 381.
Thaloor, D., Singh, A. K., Sidhu, G. S., Prasad, P. V., Kleinman, H. K., and Maheshwari, R. K. (1998)Cell Growth Differ.,9, 305–312.
Igura, K., Ohta, T., Kuroda, Y., and Kaji, K. (2001)Cancer Lett.,171, 11–16.
Theriault, A., Chao, J. T., Wang, Q., Gapor, A., and Adeli, K. (1999)Clin. Biochem.,32, 309–319.
Vincent, L., Chen, W., Hong, L., Mirshahi, F., Mishal, Z., Mirshahi-Khorassani, T., Vannier, J. P., Soria, J., and Soria, C. (2001)FEBS Lett.,495, 159–166.
Park, H. J., Kong, D., Iruela-Arispe, L., Begley, U., Tang, D., and Galper, J. B. (2002)Circ. Res.,91, 143–150.
Parker, R. A., Pearce, B. C., Clark, R. W., Gordon, D. A., and Wright, J. J. (1993)J. Biol. Chem.,268, 11230–11238.
Tang, F. Y., and Meydani, M. (2001)Nutr. Cancer,41, 119–125.
Jiang, C., Jiang, W., Ip, C., Ganther, H., and Lu, J. (1999)Mol. Carcinog.,26, 213–225.
Cai, T., Fassina, G., Morini, M., Aluigi, M. G., Masiello, L., Fontanini, G., D'Agostini, F., De Flora, S., Noonan, D. M., and Albini, A. (1999)Lab. Invest.,79, 1151–1159.
Mantell, D. J., Owens, P. E., Bundred, N. J., Mawer, E. B., and Canfield, A. E. (2000)Circ. Res.,87, 214–220.
Kanayasu, T., Morita, I., Nakao-Hayashi, J., Asuwa, N., Fujisawa, C., Ishii, T., Ito, H., and Murota, S. (1991)Lipids,26, 271–276.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Miyazawa, T., Inokuchi, H., Hirokane, H. et al. Anti-angiogenic Potential of Tocotrienolin vitro . Biochemistry (Moscow) 69, 67–69 (2004). https://doi.org/10.1023/B:BIRY.0000016353.18007.39
Issue Date:
DOI: https://doi.org/10.1023/B:BIRY.0000016353.18007.39